Artículos de revistas sobre el tema "Generation of negative triples"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Generation of negative triples".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Vallée-Tourangeau, Frédéric, Neville G. Austin y Sandra Rankin. "Inducing a Rule in Wason's 2–4–6 Task: A Test of the Information-Quantity and Goal-Complementarity Hypotheses". Quarterly Journal of Experimental Psychology Section A 48, n.º 4 (noviembre de 1995): 895–914. http://dx.doi.org/10.1080/14640749508401422.
Texto completoVallée-Tourangeau, Frédéric. "Utilities in the 2-4-6 Task". Experimental Psychology 59, n.º 5 (1 de mayo de 2012): 265–71. http://dx.doi.org/10.1027/1618-3169/a000152.
Texto completoWang, Liuquan. "Arithmetic identities and congruences for partition triples with 3-cores". International Journal of Number Theory 12, n.º 04 (10 de abril de 2016): 995–1010. http://dx.doi.org/10.1142/s1793042116500627.
Texto completoTierno, Domenico, Gabriele Grassi, Serena Scomersi, Marina Bortul, Daniele Generali, Fabrizio Zanconati y Bruna Scaggiante. "Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications". International Journal of Molecular Sciences 24, n.º 11 (2 de junio de 2023): 9688. http://dx.doi.org/10.3390/ijms24119688.
Texto completoWu, Jiande, Tarun K. K. Mamidi, Lu Zhang y Chindo Hicks. "Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer". International Journal of Genomics 2020 (7 de julio de 2020): 1–16. http://dx.doi.org/10.1155/2020/2641370.
Texto completoLin, Po‐Han, Ming Chen, Li‐Wei Tsai, Chiao Lo, Tzu‐Chun Yen, Thomas Yoyan Huang, Chih‐Kai Chen, Sheng‐Chih Fan, Sung‐Hsin Kuo y Chiun‐Sheng Huang. "Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer". Cancer Science 111, n.º 4 (19 de febrero de 2020): 1375–84. http://dx.doi.org/10.1111/cas.14313.
Texto completoWu, Jiande, Tarun Karthik Kumar Mamidi, Lu Zhang y Chindo Hicks. "Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer". Cancers 12, n.º 6 (12 de junio de 2020): 1559. http://dx.doi.org/10.3390/cancers12061559.
Texto completoRaftery, Martin J., Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens-Uwe Blohmer y Gabriele Pecher. "Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer". International Journal of Molecular Sciences 24, n.º 10 (20 de mayo de 2023): 9038. http://dx.doi.org/10.3390/ijms24109038.
Texto completoZhang, Zhenghang, Jinlu Jia, Yalin Wan, Yang Zhou, Yuting Kong, Yurong Qian y Jun Long. "TransR*: Representation learning model by flexible translation and relation matrix projection". Journal of Intelligent & Fuzzy Systems 40, n.º 5 (22 de abril de 2021): 10251–59. http://dx.doi.org/10.3233/jifs-202177.
Texto completoBen-Baruch, Noa, Tamar Peretz-Yablonski, Georgeta Fried, Moshe J. Inbar, Yousef Samih, Victoria Neiman, Bella Nisenbaum et al. "Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel." Journal of Clinical Oncology 32, n.º 15_suppl (20 de mayo de 2014): 1028. http://dx.doi.org/10.1200/jco.2014.32.15_suppl.1028.
Texto completoThouvenot, B., S. Verdun, J. Tomasina, B. Hilselberger, M. Brulliard, L. Bonnard, M. Trarbach, J. Armand, V. Ogier y B. E. Bihain. "P272 Using next-generation sequencing to predict clinical outcome of triple negative breast cancer". Breast 24 (marzo de 2015): S120. http://dx.doi.org/10.1016/s0960-9776(15)70304-8.
Texto completoElsayed, Islam y Yoshiki Nishi. "A Feasibility Study on Power Generation from Solar Thermal Wind Tower: Inclusive Impact Assessment Concerning Environmental and Economic Costs". Energies 11, n.º 11 (16 de noviembre de 2018): 3181. http://dx.doi.org/10.3390/en11113181.
Texto completoCaiazza, Francesco, Alyson Murray, Stephen F. Madden, Naoise C. Synnott, Elizabeth J. Ryan, Norma O’Donovan, John Crown y Michael J. Duffy. "Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells". Endocrine-Related Cancer 23, n.º 4 (abril de 2016): 323–34. http://dx.doi.org/10.1530/erc-16-0068.
Texto completoLips, Esther H., Magali Michaut, Lennart Mulder, Nicolle Besselink, Marlous L. Hoogstraat, Marco J. Koudijs, Emile E. Voest et al. "Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC)." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 1010. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1010.
Texto completoHu, Zhiwei, Rulong Shen, Amanda Campbell, Elizabeth McMichael, Lianbo Yu, Bhuvaneswari Ramaswamy, Cheryl A. London, Tian Xu y William E. Carson. "Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON". Cancer Immunology Research 6, n.º 6 (5 de abril de 2018): 671–84. http://dx.doi.org/10.1158/2326-6066.cir-17-0343.
Texto completoWang, Wei, Hao Chen, Yang Xie, Sayantap Datta, Wei Li y Ruiwen Zhang. "Abstract 678: Experimental therapy of triple negative breast cancer with next-generation of MDM2 inhibitors". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 678. http://dx.doi.org/10.1158/1538-7445.am2024-678.
Texto completoDenu, Ryan A., Cissimol P. Joseph, Elizabeth S. Urquiola, Precious S. Byrd, Richard K. Yang, Ravin Ratan, Maria Alejandra Zarzour et al. "Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors". Cancers 16, n.º 9 (27 de abril de 2024): 1707. http://dx.doi.org/10.3390/cancers16091707.
Texto completoKareev, Yaakov, Naftali Halberstadt y Dorit Shafir. "Improving Performance and Increasing the Use of Non-Positive Testing in a Rule-Discovery Task". Quarterly Journal of Experimental Psychology Section A 46, n.º 4 (noviembre de 1993): 729–42. http://dx.doi.org/10.1080/14640749308401036.
Texto completoHossain, Fokhrul, Samarpan Majumder, Justin David y Lucio Miele. "Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions". Cancers 13, n.º 15 (26 de julio de 2021): 3739. http://dx.doi.org/10.3390/cancers13153739.
Texto completoAlewine, Christine, Laiman Xiang, Takao Yamori, Gerhard Niederfellner, Klaus Bosslet y Ira Pastan. "Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers". Molecular Cancer Therapeutics 13, n.º 11 (19 de septiembre de 2014): 2653–61. http://dx.doi.org/10.1158/1535-7163.mct-14-0132.
Texto completoZhu, X., J. Bayani, M. Dewan, H. Tovey, L. Kilburn, K. Taylor, J. Banerji et al. "307P Identifying new biological subgroups of triple-negative breast cancer using next-generation integrative clustering pipeline". Annals of Oncology 34 (octubre de 2023): S306—S307. http://dx.doi.org/10.1016/j.annonc.2023.09.503.
Texto completoBhattarai, Shristi, Geetanjali Saini, Hongxiao Li, Gaurav Seth, Timothy B. Fisher, Emiel A. M. Janssen, Umay Kiraz, Jun Kong y Ritu Aneja. "Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning". Diagnostics 14, n.º 1 (28 de diciembre de 2023): 74. http://dx.doi.org/10.3390/diagnostics14010074.
Texto completoKhandelwal, Soni, Mallory Boylan, Gilbert Kirsch, Julian E. Spallholz y Lauren S. Gollahon. "Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer". Antioxidants 9, n.º 2 (5 de febrero de 2020): 138. http://dx.doi.org/10.3390/antiox9020138.
Texto completoPircher, Magdalena, Thomas Winder y Andreas Trojan. "Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported Outcome". Case Reports in Oncology 14, n.º 1 (29 de marzo de 2021): 616–21. http://dx.doi.org/10.1159/000513905.
Texto completoHerrera Juarez, Mercedes, Pablo Tolosa Ortega, Ana Sanchez de Torre y Eva Ciruelos Gil. "Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features". Breast Care 15, n.º 3 (2020): 208–16. http://dx.doi.org/10.1159/000508758.
Texto completoDesa, Danielle E., Wencheng Wu, Robert M. Brown, Edward B. Brown, Robert L. Hill, Bradley M. Turner y Edward B. Brown. "Second-Harmonic Generation Imaging Reveals Changes in Breast Tumor Collagen Induced by Neoadjuvant Chemotherapy". Cancers 14, n.º 4 (9 de febrero de 2022): 857. http://dx.doi.org/10.3390/cancers14040857.
Texto completoYang, Biyao, Rui Sang, Yi Li, Ewa Goldys y Wei Deng. "Abstract 5743: Liposome platform enables X-ray induced photodynamic therapy treatment against human triple negative breast cancer cells". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 5743. http://dx.doi.org/10.1158/1538-7445.am2024-5743.
Texto completoNagahashi, Masayuki, Tetsu Hayashida, Yuko Kitagawa, Manabu Futamura, Kazuhiro Yoshida, Takashi Kuwayama, Seigo Nakamura et al. "Comprehensive genomic sequencing for triple negative breast cancer in Japan." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): e23122-e23122. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e23122.
Texto completoAshourpour, Maryam, Fatemeh Mostafavi Hosseini, Mohsen Amini, Ebrahim Saeedian Moghadam, Faranak Kazerouni, Seyed Yousef Arman y Zahra Shahsavari. "Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468". Asian Pacific Journal of Cancer Prevention 22, n.º 7 (1 de julio de 2021): 2079–87. http://dx.doi.org/10.31557/apjcp.2021.22.7.2079.
Texto completoWeisman, Paul S., Charlotte K. Y. Ng, Edi Brogi, Rachel E. Eisenberg, Helen H. Won, Salvatore Piscuoglio, Maria R. De Filippo et al. "Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology". Modern Pathology 29, n.º 5 (4 de marzo de 2016): 476–88. http://dx.doi.org/10.1038/modpathol.2016.39.
Texto completoSangiorgio, Valentina, Rocco Giovanni Piazza, Federica Mottadelli, Fabio Pagni, Inzoli Elena, Carlo Gambacorti-Passerini, Gianni Cazzaniga y Elena Maria Elli. "P1056: NEXT GENERATION SEQUENCING IDENTIFIES SUBGROUPS OF PATIENTS WITH TRIPLE NEGATIVE/ PRIMARY THROMBOCYTOSIS WITH DIFFERENT CLINICAL OUTCOMES". HemaSphere 7 (agosto de 2023): e7820571. http://dx.doi.org/10.1097/01.hs9.0000971120.78205.71.
Texto completoBerisha, Eranda, Maria del Carmen Chacon Castro, Adnin Ashrafi, Narges Salamat, Parinaz Sadat Alemi y Li Zhang. "Abstract 4942: Heme targeting and its mechanistic role in triple-negative breast cancer suppression". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 4942. http://dx.doi.org/10.1158/1538-7445.am2023-4942.
Texto completoYun, Jiwon, Jung-Ah Kim, Byungjin Hwang, Hee Sue Park, Kyongok Im, Sung-Min Kim, Dajeong Jeong, Kyu Min Lim, Duhee Bang y Dong Soon Lee. "Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics". Blood 132, Supplement 1 (29 de noviembre de 2018): 1772. http://dx.doi.org/10.1182/blood-2018-99-118013.
Texto completoMorris, Lindsay Kaye, Matthew Stein, Saradasri Karri, Srishti Sareen, Kruti Patel, Gregory A. Vidal, Lee Steven Schwartzberg y Michael Gary Martin. "Distribution of receptor tyrosine kinase (RTK) nsSNPs in breast cancer (BC) patients (pts) using next-generation sequencing (NGS)." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): 1080. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1080.
Texto completoKalyane, Dnyaneshwar, Suryanarayana Polaka, Nupur Vasdev y Rakesh Kumar Tekade. "CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells". Pharmaceutics 14, n.º 12 (6 de diciembre de 2022): 2734. http://dx.doi.org/10.3390/pharmaceutics14122734.
Texto completoSvidnicki, Maria Carolina Costa Melo, Paula De Melo Campos, Moisés Alves Ferreira Filho, Caio Augusto Leme Fujiura, Tetsuichi Yoshizato, Hideki Makishima, Seishi Ogawa y Sara T. Olalla Saad. "Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms". Blood 134, Supplement_1 (13 de noviembre de 2019): 5395. http://dx.doi.org/10.1182/blood-2019-128764.
Texto completoDameri, Martina, Lorenzo Ferrando, Gabriella Cirmena, Claudio Vernieri, Giancarlo Pruneri, Alberto Ballestrero y Gabriele Zoppoli. "Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer". International Journal of Molecular Sciences 22, n.º 13 (1 de julio de 2021): 7154. http://dx.doi.org/10.3390/ijms22137154.
Texto completoBahman, Fatemah, Valeria Pittalà, Mohamed Haider y Khaled Greish. "Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer". Journal of Personalized Medicine 11, n.º 6 (15 de junio de 2021): 559. http://dx.doi.org/10.3390/jpm11060559.
Texto completoHe, W., Y. Zhang, Y. Deng y D. Kabelitz. "Induction of TCR-gamma delta expression on triple-negative (CD3-4-8-) human thymocytes. Comparative analysis of the effects of IL-4 and IL-7." Journal of Immunology 154, n.º 8 (15 de abril de 1995): 3726–31. http://dx.doi.org/10.4049/jimmunol.154.8.3726.
Texto completoBian, Yanlin, Tong Lin, Tanja Jakos, Xiaodong Xiao y Jianwei Zhu. "The Generation of Dual-Targeting Fusion Protein PD-L1/CD47 for the Inhibition of Triple-Negative Breast Cancer". Biomedicines 10, n.º 8 (30 de julio de 2022): 1843. http://dx.doi.org/10.3390/biomedicines10081843.
Texto completoWang, Nan, Kun Li, Wenfa Huang, Weiyao Kong, Xiaoran Liu, Weijie Shi, Feng Xie et al. "Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing". Chinese Journal of Cancer Research 32, n.º 2 (2020): 149–62. http://dx.doi.org/10.21147/j.issn.1000-9604.2020.02.03.
Texto completoHuang, Xin, Huanwen M. Wu, Changbin Zhu, Di Shao, Dan Guo, Yidong Zhou, Yan Lin et al. "Next generation sequencing reveals CCNE1 amplification as an independent prognostic factor for triple negative breast cancer (TNBC) patients." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): 558. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.558.
Texto completoLanders, Mark, Rhonda Meredith, Jerry Lee, Yipeng Wang, Byung-In Lee y Joseph Monforte. "Next-generation sequencing mutational analysis of triple-negative breast cancer patients from matched FFPE and fresh frozen samples." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): 1058. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1058.
Texto completoAnders, Carey K., Vandana Abramson, Tira Tan y Rebecca Dent. "The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics". American Society of Clinical Oncology Educational Book, n.º 36 (mayo de 2016): 34–42. http://dx.doi.org/10.1200/edbk_159135.
Texto completoKhadela, Avinash, Vivek P. Chavda, Shruti Soni, Kaivalya Megha, Aanshi J. Pandya y Lalitkumar Vora. "Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer". Cancers 15, n.º 1 (30 de diciembre de 2022): 233. http://dx.doi.org/10.3390/cancers15010233.
Texto completoAndreidesz, Kitti, Balazs Koszegi, Dominika Kovacs, Viola Bagone Vantus, Ferenc Gallyas y Krisztina Kovacs. "Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells". International Journal of Molecular Sciences 22, n.º 4 (19 de febrero de 2021): 2056. http://dx.doi.org/10.3390/ijms22042056.
Texto completoShiau, Jun-Ping, Cheng-Che Wu, Shu-Jyuan Chang, Mei-Ren Pan, Wangta Liu, Fu Ou-Yang, Fang-Ming Chen, Ming-Feng Hou, Shen-Liang Shih y Chi-Wen Luo. "FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer". Biomedicines 9, n.º 12 (29 de noviembre de 2021): 1789. http://dx.doi.org/10.3390/biomedicines9121789.
Texto completoSubhan, Md Abdus, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide y Valdimir P. Torchilin. "Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type". Cancers 15, n.º 8 (8 de abril de 2023): 2204. http://dx.doi.org/10.3390/cancers15082204.
Texto completoJagadish, Nirmala, Sonika Devi, Namita Gupta, Vitusha Suri y Anil Suri. "Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells in vitro and in vivo". Tumor Biology 42, n.º 4 (abril de 2020): 101042832091447. http://dx.doi.org/10.1177/1010428320914477.
Texto completoMohammadhosseinpour, Sepideh, Alexx Weaver, Meenakshi Sudhakaran, Linh-Chi Ho, Tra Le, Andrea I. Doseff y Fabricio Medina-Bolivar. "Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells". Cancers 15, n.º 2 (7 de enero de 2023): 399. http://dx.doi.org/10.3390/cancers15020399.
Texto completo